dc.contributor.author | McMaster, Mitchell | |
dc.contributor.author | Fielding, Elaine | |
dc.contributor.author | Lim, David | |
dc.contributor.author | Moyle, Wendy | |
dc.contributor.author | Beattie, Elizabeth | |
dc.contributor.author | The AusQoL Group | |
dc.date.accessioned | 2021-11-10T04:10:25Z | |
dc.date.available | 2021-11-10T04:10:25Z | |
dc.date.issued | 2018 | |
dc.identifier.issn | 1741-203X | en_US |
dc.identifier.doi | 10.1017/S1041610217002447 | en_US |
dc.identifier.uri | http://hdl.handle.net/10072/410006 | |
dc.description.abstract | Background: Behavioral and psychological symptoms of dementia (BPSD) are a common problem in long-term care facilities (LTC). Clinical guidelines dictate that first-line treatments for BPSD are psychosocial and behavioral interventions; if these are unsuccessful, psychotropic medications may be trialed at low doses and their effects can be monitored. Methods: There have previously been no studies with nationally representative samples to investigate psychotropic administration in LTCs in Australia. This study determines the prevalence of psychotropic administration in a representative stratified random sample of 446 residents living with dementia from 53 Australian LTCs. Questionnaire and medical chart data in this study is drawn from a larger cross-sectional, mixed methods study on quality of life in Australian LTCs. Results: It was found that 257 (58%) residents were prescribed psychotropic medications including: antipsychotics (n = 160, 36%), benzodiazepines (n = 136, 31%), antidepressants (n = 117, 26%), and anti-dementia medications (n = 9, 2%). BPSD were found to be very common in the sample, with 82% (n = 364) of participants experiencing at least one BPSD. The most prevalent BPSD were depression (n = 286, 70%) and agitation (n = 299, 67%). Conclusions: Although detailed background information was not collected on individual cases, the prevalence found is indicative of systematic industry-wide, over-prescription of psychotropic medications as a first-line treatment for BPSD. This study highlights a clear need for further research and interventions in this area. | en_US |
dc.description.peerreviewed | Yes | en_US |
dc.language | English | en_US |
dc.publisher | Cambridge University Press | en_US |
dc.publisher.place | United Kingdom | |
dc.relation.ispartofpagefrom | 1019 | en_US |
dc.relation.ispartofpageto | 1026 | en_US |
dc.relation.ispartofissue | 7 | en_US |
dc.relation.ispartofjournal | International Psychogeriatrics | en_US |
dc.relation.ispartofvolume | 30 | en_US |
dc.subject.fieldofresearch | Biomedical and clinical sciences | en_US |
dc.subject.fieldofresearch | Psychology | en_US |
dc.subject.fieldofresearchcode | 32 | en_US |
dc.subject.fieldofresearchcode | 52 | en_US |
dc.subject.keywords | Social Sciences | en_US |
dc.subject.keywords | Science & Technology | en_US |
dc.subject.keywords | Life Sciences & Biomedicine | en_US |
dc.subject.keywords | Psychology, Clinical | en_US |
dc.subject.keywords | Geriatrics & Gerontology | en_US |
dc.title | A cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: Issues of concern | en_US |
dc.type | Journal article | en_US |
dc.type.description | C1 - Articles | en_US |
dcterms.bibliographicCitation | McMaster, M; Fielding, E; Lim, D; Moyle, W; Beattie, E; The AusQoL Group, A cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: Issues of concern, International Psychogeriatrics, 2018, 30 (7), pp. 1019-1026 | en_US |
dc.date.updated | 2021-11-10T04:03:53Z | |
gro.hasfulltext | No Full Text | |
gro.griffith.author | Moyle, Wendy | |